You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

interleukin 1 beta

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Periodontitis, Gingivitis, Periodontal Health Trial in Aydin (Periodontal clinical measurements, GCF and saliva sampling)

Completed
  • Periodontitis
  • +2 more
  • Periodontal clinical measurements, GCF and saliva sampling
  • Aydın, Turkey
    Aydın Adnan Menderes University
Oct 26, 2023

Allergic Contact Dermatitis Trial (Anakinra, Sodium Chloride 9mg/ml Injection)

Not yet recruiting
  • Allergic Contact Dermatitis
  • (no location specified)
Aug 9, 2022

GCF Galectin-3 and Interleukin-1beta Levels in Periodontitis.

Completed
  • Periodontitis
  • Periodontal Inflammation
  • Periodontal clinical measurements and gingival crevicular fluid sampling
  • Aydın, Turkey
    Adnan Menderes University, Faculty of Dentistry, Department of P
Jul 4, 2022

Beta Endorphins,Interleukin 1 and Interleukin 38 in Covid

Recruiting
  • Covid Patients
  • βeta endorphins, interleukin 6 and interleukin 38
  • Assiut, Egypt
    Assiut university
Jan 22, 2022

Colorectal Cancer, Hematologic Malignancy, Rectum Cancer Trial in Cleveland (Vactosertib, Fludarabine Phosphate,

Recruiting
  • Colorectal Cancer
  • +11 more
  • Cleveland, Ohio
    University Hospitals Cleveland Medical Center, Case Comprehensiv
Jan 18, 2023

Metastatic Melanoma, Stage III Cutaneous Melanoma AJCC v7, Stage IV Cutaneous Melanoma AJCC v6 and v7 Trial in Houston

Active, not recruiting
  • Metastatic Melanoma
  • +2 more
  • Aldesleukin
  • +6 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 18, 2022

Hematologic and Lymphocytic Disorder, Hematopoietic and Lymphoid Cell Tumor Trial in United States (drug, other, biological)

Recruiting
  • Hematologic and Lymphocytic Disorder
  • Hematopoietic and Lymphoid Cell Neoplasm
  • Placebo Administration
  • +3 more
  • Duarte, California
  • +3 more
Dec 14, 2022

Stage III Cutaneous Melanoma AJCC v7, Stage IIIA Cutaneous Melanoma AJCC v7, Stage IIIB Cutaneous Melanoma AJCC v7 Trial in

Completed
Has Results
  • Stage III Cutaneous Melanoma AJCC v7
  • +5 more
  • Aldesleukin
  • +4 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Oct 17, 2022

Advanced Solid Tumor, Unresectable Solid Tumor, Melanoma Trial in Australia, Canada, United States (MDNA11 Monotherapy, MDNA11

Recruiting
  • Advanced Solid Tumor
  • +24 more
  • MDNA11 Monotherapy
  • MDNA11 in combination with checkpoint inhibitor
  • Santa Monica, California
  • +7 more
Nov 1, 2022

Metastatic Melanoma, Stage IIIB Cutaneous Melanoma AJCC v7, Stage IIIC Cutaneous Melanoma AJCC v7 Trial in Houston (biological,

Completed
  • Metastatic Melanoma
  • +3 more
  • Aldesleukin
  • +6 more
  • Houston, Texas
    M D Anderson Cancer Center
Oct 27, 2022

Recurrent Adult Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in Houston (drug, biological, other)

Completed
  • Recurrent Adult Acute Myeloid Leukemia
  • Refractory Acute Myeloid Leukemia
  • Houston, Texas
    M D Anderson Cancer Center
Jun 18, 2021

Leiomyosarcoma Trial in Bad Saarow, Berlin (Dinutuximab Beta, Zoledronic acid, Interleukin-2)

Recruiting
  • Leiomyosarcoma
  • Dinutuximab Beta, Zoledronic acid, Interleukin-2
  • Bad Saarow, Germany
  • +1 more
Jun 2, 2022

Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Erythroid Leukemia, Acute Megakaryoblastic Leukemia

Completed
  • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • +14 more
  • Aldesleukin
  • +7 more
  • Houston, Texas
    M D Anderson Cancer Center
Jul 31, 2022

Neuroblastoma Recurrent Trial in Hong Kong (Natural killer cell, Dinutuximab beta, Interleukin-2)

Recruiting
  • Neuroblastoma Recurrent
  • Natural killer cell
  • +4 more
  • Hong Kong, Hong Kong
    Hong Kong Children's Hospital
Feb 22, 2023

Interleukin-1ß Gene Polymorphism May Increase Risk of Developing

Completed
  • Lumbar Disc Degeneration
  • +2 more
    • Istanbul, Turkey
      Yeditepe University
    Oct 31, 2022

    Nasal IL 1 Beta ,IL 3 Level and Their Effects in COPD Patients

    Not yet recruiting
    • Copd Patients
    • IL B,IL 3 in nasal swap and serum
    • (no location specified)
    Aug 4, 2023

    Blastic Plasmacytoid Dendritic Cell Tumor Trial in Houston (Cyclophosphamide, Cytarabine, Dexamethasone)

    Recruiting
    • Blastic Plasmacytoid Dendritic Cell Neoplasm
    • Houston, Texas
      M D Anderson Cancer Center
    Nov 30, 2021

    Multiple Sclerosis Trial in Cairo (Blood sample collection)

    Recruiting
    • Multiple Sclerosis
    • Blood sample collection
    • Cairo, Egypt
      Nasser Institute for Research and Treatment
    Feb 21, 2023

    Hyperinsulinemia, PreDiabetes Trial in Basel (Anakinra, Placebo)

    Not yet recruiting
    • Hyperinsulinemia
    • PreDiabetes
    • Basel, Switzerland
      University Hospital Basel
    May 2, 2023

    Multiple Myeloma Trial (BCMA-TGFß CAR-T cells (0.75 x10^6 cells/kg), BCMA-TGFß CAR-T cells (1 x 10^6 cells/kg), BCMA-TGFß CAR-T

    Not yet recruiting
    • Multiple Myeloma
    • BCMA-TGFβ CAR-T cells (0.75 x10^6 cells/kg)
    • +3 more
    • (no location specified)
    Jul 28, 2023

    Type 1 Diabetes Trial in Nijmegen (68Ga-NODAGA-Exendin-4)

    Recruiting
    • Type 1 Diabetes
    • Nijmegen, Gelderland, Netherlands
      Radboud University Medical Center
    Nov 17, 2022

    Type 1 Diabetes Trial in Seattle (Verapamil)

    Completed
    • Type 1 Diabetes
    • Seattle, Washington
      Benaroya Research Institute
    Apr 27, 2023

    Kidney Cancer Trial in Tampa (Pembrolizumab, Interleukin-2)

    Active, not recruiting
    Has Results
    • Kidney Cancer
    • Tampa, Florida
      H. Lee Moffitt Cancer Center and Research Institute
    Jun 21, 2022

    Acute Myeloid Leukemia, Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Cord Blood Transplant Recipient Trial in Houston

    Recruiting
    • Acute Myeloid Leukemia
    • +4 more
    • Recombinant Interleukin-7
    • Houston, Texas
      M D Anderson Cancer Center
    Jan 26, 2023

    Esophageal Cancer, Pancreas Cancer, Ovarian Cancer Trial in Edegem (IL15-transpresenting WT1-targeted Dendritic Cell Vaccine)

    Not yet recruiting
    • Esophageal Cancer
    • +3 more
    • IL15-transpresenting WT1-targeted Dendritic Cell Vaccine
    • Edegem, Belgium
      Antwerp University Hospital
    Jul 19, 2023